VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PTHLPheton Holdings Ltd Class A Ordinary Shares
$0.28$2M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

PTHL logoPheton Holdings Ltd Class A Ordinary Shares(PTHL)Earnings, Financials & Key Ratios

PTHL•NASDAQ
$0.28
Price updated Jun 20, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryImaging, radiation, and oncology devices
AboutPheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd operates as a subsidiary of ZJW (BVI) LTD.Show more
  • Revenue$448K-28.7%
  • EBITDA-$698K-186.4%
  • Net Income-$661K-174.0%
  • EPS (Diluted)-0.05-212.7%
  • Gross Margin85.04%+13.5%
  • EBITDA Margin-155.64%-301.7%
  • Operating Margin-171.8%-252.1%
  • Net Margin-147.48%-284.3%
  • ROE-20.37%+63.6%

PTHL Price & Volume

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) stock price & volume — 10-year historical chart

Loading chart...

Structural Revenue Contraction Masks Operational Margin Deficit

Investment Thesis • Updated 2024Q4

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Operational scale and liquidity
"Pheton Holdings faces a challenging outlook as its project-based procurement model in the Chinese healthcare sector drives significant revenue volatility, evidenced by a 28.7% year-over-year decline. While the company maintains high gross margins of 83.9%, it struggles to achieve profitability, with operating margins deteriorating to -191.8% due to an inefficient fixed cost structure. Investors should remain cautious as the company's reliance on cash reserves to fund ongoing operational deficits, coupled with a shift to a $522.9K retained earnings deficit, suggests a high risk of continued value erosion."

Verdict Logic

the company's inability to convert its 83.9% gross margin into positive net income, resulting in a -157.9% net margin, indicates a fundamental failure to achieve sustainable operational scale.

PTHL Growth Metrics

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-13.92%
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-

Return on Capital

10 Years-15.77%
5 Years-15.77%
3 Years-24.88%
Last Year-23.35%

Peers Comparison

Key metrics vs top competitors for Pheton Holdings Ltd Class A Ordinary Shares (PTHL)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
PTHL logoPTHLPheton Holdings Ltd Class A Ordinary SharesCurrent
$0.28$2.16M-5.42-28.7%-147.48%-20.37%—
CANG logoCANGCango Inc.
$0.20$77.78M-0.12498.08%-91.96%-60.5%—
RCON logoRCONRecon Technology, Ltd.
$0.41$8.25M-0.60-3.73%-64.25%-9.15%—
CLPS logoCLPSCLPS Incorporation
$0.85$25.33M-3.2815.17%-3.05%-15.02%—
CODA logoCODACoda Octopus Group, Inc.
$9.60$108.3M25.9530.75%17.66%8.33%—
AIXI logoAIXIXiao-I Corporation
$1.99$1.05M-0.01-82.47%-140.37%——

Compare PTHL vs Peers

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CANG

Most directly comparable listed peer for PTHL.

Scale Benchmark

vs BABA

Larger-name benchmark to compare PTHL against a more recognizable public peer.

Peer Set

Compare Top 5

vs CANG, RCON, CLPS, CODA

Get notified when PTHL posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

PTHL Frequently Asked Questions

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Pheton Holdings Ltd Class A Ordinary Shares's revenue?

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) reported $0.9M in revenue for fiscal year 2024. This represents a 34% increase from $0.7M in 2021.

How fast is Pheton Holdings Ltd Class A Ordinary Shares growing?

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) saw revenue decline by 28.7% over the past year.

Is PTHL profitable?

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) reported a net loss of $0.9M for fiscal year 2024.

Dividend & Returns
What is PTHL's return on equity?

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) has a return on equity (ROE) of -20.4%. Negative ROE indicates the company is unprofitable.

What is Pheton Holdings Ltd Class A Ordinary Shares's free cash flow?

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) had negative free cash flow of $0.8M in fiscal year 2024, likely due to heavy capital investments.

What if you invested $1,000 in PTHL back in 2021?

Total return calculator · dividends reinvested · 5+ years of data

See returns →